Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04440839 · ClinicalTrials.gov registry record · NA

Implementation of Telemedicine for Patient With Lower Extremity Wounds

A NA study of Peripheral Arterial Disease and Diabetic Foot Ulcer, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
116
Enrollment target
1
Study location

NCT04440839 is a NA study of Peripheral Arterial Disease and Diabetic Foot Ulcer that has completed, run by University of California, Davis. The registered enrollment target is 116 participants, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04440839, a NA study of Peripheral Arterial Disease and Diabetic Foot Ulcer, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
116 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine if patients with lower extremity wounds in rural communities who undergo specialty referral through telemedicine have expedited care compared to patients who are treated through standard in person referral.

Interventions

  • OTHER Telemedicine specialty consultation

Study Locations (1)

California

  • Misty D. Humphries - Sacramento

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2020-03-01
Est. Completion 2023-12-31
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT04440839

The ClinicalTrials.gov registry entry for NCT04440839 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (97% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Telemedicine specialty consultation is the first listed.

NCT04440839 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04440839 about?

NCT04440839 is a clinical study titled "Implementation of Telemedicine for Patient With Lower Extremity Wounds". The objective of this study is to determine if patients with lower extremity wounds in rural communities who undergo specialty referral through telemedicine have expedited care compared to patients who are treated through standard in person referral.

What is the current status of trial NCT04440839?

This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2020-03-01. Estimated completion is 2023-12-31.

What conditions does trial NCT04440839 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease, Diabetic Foot Ulcer, Peripheral Artery Disease, Diabetic Foot, Peripheral Vascular Diseases.

What interventions are being tested in trial NCT04440839?

The interventions under investigation include: Telemedicine specialty consultation (OTHER).

Who is sponsoring clinical trial NCT04440839?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04440839 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Arterial Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.